Home > Boards > US Listed > Biotechs > ChromaDex Corp. (CDXC)

I got a promo from them this morning

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cantwate Member Profile
 
Followed By 3
Posts 167
Boards Moderated 0
Alias Born 07/11/03
160x600 placeholder
ChromaDex launches Tru Niagen® in Walmart Stores; Shares Pop 7% TipRanks - 6/8/2021 10:21:11 AM
ChromaDex and Walmart Launch Tru Niagen® in 3,800 Walmart Stores Across the United States Business Wire - 6/7/2021 6:33:00 AM
ChromaDex EPS misses by $0.03, misses on revenue Seeking Alpha - 5/6/2021 4:41:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:08:28 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 4:03:44 PM
ChromaDex Corporation Reports First Quarter 2021 Financial Results Business Wire - 5/6/2021 4:02:00 PM
ChromaDex and Ro partner for Niagen supply Seeking Alpha - 5/4/2021 6:36:07 AM
ChromaDex and Ro Partner for New Product Development Business Wire - 5/4/2021 6:33:00 AM
ChromaDex to Present at Benzinga’s Global Small Cap Conference on May 13, 2021 Business Wire - 5/3/2021 6:33:00 AM
ChromaDex to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 Business Wire - 4/29/2021 6:33:00 AM
ChromaDex inks supply agreement for Niagen Seeking Alpha - 4/28/2021 7:10:38 AM
ChromaDex and Health & Happiness (H&H) Group Announce Supply Agreement for Niagen® Business Wire - 4/28/2021 6:33:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 4/22/2021 4:32:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/21/2021 4:23:12 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/21/2021 4:19:09 PM
ChromaDex Appoints Fadi Karam as Chief Marketing Officer Business Wire - 4/19/2021 6:33:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 4/9/2021 10:57:49 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2021 7:25:30 PM
ChromaDex inks research collaboration in citrin deficiency Seeking Alpha - 3/31/2021 7:00:12 AM
ChromaDex and the Citrin Foundation Announce Global Research Collaboration Exploring Citrin Deficiency Business Wire - 3/31/2021 6:33:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/25/2021 10:27:03 AM
ChromaDex to Present at the Lytham Partners Spring 2021 Investor Conference Business Wire - 3/24/2021 6:33:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/23/2021 4:34:56 PM
ChromaDex to Present at the Zooming with LD Virtual Investor Conference Business Wire - 3/18/2021 6:33:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/17/2021 6:46:50 PM
cantwate   Wednesday, 07/17/19 02:39:06 PM
Re: cantwate post# 2939
Post # of 3025 
I got a promo from them this morning and asked about a way to measure NAD. This is the entire response.


Cheri Thomas (Tru Niagen)
Jul 17, 11:18 PDT

Hello,

Thank you for your email and interest in TRU NIAGEN®. While some scientists have developed methods to measure NAD+ levels for research, they have not yet translated these measurements from the laboratory bench to the clinic. At some point in the future, we expect the analytical method to be standardized so that NAD+ analysis can be introduced into clinical laboratory use. More work will be needed to bring this exciting technology to the bedside where it is informative for patients and their healthcare providers.

One thing to keep in mind is that every tissue has its own machinery to make and to break down NAD+. Blood is a convenient material for testing a person’s response to taking TRU NIAGEN®, but it is not necessarily the most relevant tissue for assessing the health benefits of supplementing with NR. We and others are working on less invasive ways to assess NAD+ status in tissues beyond the blood.

We know that TRU NIAGEN is increasing NAD+ safely and effectively in people as this has been demonstrated in several published clinical trials.

Clinical trials:
https://www.nature.com/articles/ncomms12948
https://www.nature.com/articles/s41467-018-03421-7
https://www.ncbi.nlm.nih.gov/pubmed/29992272
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186459

Again, thanks for the excellent question, and your interest in TRU NIAGEN®.
Sincerely,

Cheri Thomas

TN Logo

1-888-642-4361 (1-888-NIAGEN1)

www.TruNiagen.com

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences